Polyphenols as Tyrosine Kinase Inhibitors for the Treatment of Metastatic Cancers: Current and Future Perspective

  • Saad Hussain Department of Pharmacology, Faculty of Pharmacy, Al-Rafidain University College, Baghdad 10052, Iraq
  • Qasim Mahmood Alhadidi Pharmacovigilance Unit, Department of Pharmacy, Salah Addin Health Directorate, Tikrit, Iraq https://orcid.org/0000-0003-3021-6462
Keywords: polyphenols, cancer metastasis, tyrosine kinases, chemoprevention


Cancer is the world's biggest cause of death as a whole. The higher cancer mortality rate is related to metastasis, which is a major stumbling block in cancer treatment. Polyphenols are a diverse set of antioxidant-rich natural compounds that are often used in cancer treatments as chemopreventives and adjuvants. To find publications that highlight the topic of this review paper, a thorough literature search was conducted in several electronic databases such as PubMed Central, Google Scholar, Scopus, and Medline. Many signaling pathways are involved in the metastatic cascade, including the tyrosine kinase pathway. Tyrosine kinases are a group of enzymes involved in the control of cancer spread. Polyphenols' true role in cancer metastasis remains unappreciated, despite a large body of research proving their antimetastatic effects. As a result, the current work lays out cancer metastasis signaling pathways, stressing the importance of tyrosine kinases in the metastatic process. Polyphenols can suppress tyrosine kinase activity, which contributes to their antimetastatic characteristics. The importance of polyphenols in preventing cancer metastasis by interfering with the tyrosine kinase signaling cascade is highlighted in this work, which could lead to the development of future antimetastatic drugs.


Achen, M. G., & Stacker, S. A. (2008). Molecular control of lymphatic metastasis. Annals of the New York Academy of Sciences, 1131, 225–234. doi: 10.1196/annals.1413.020.
Adhami, V. M., Afaq, F., & Mukhtar, H. (2006). Insulin-like growth factor-I axis as a pathway for cancer chemoprevention. Clinical Cancer Research, 12(19), 5611–5614. doi: 10.1158/1078-0432.CCR-06-1564.
Aggarwal, B. B., Shishodia, S., Takada, Y., Banerjee, S., Newman, R. A., Bueso-Ramos, C. E., & Price, J. E. (2005). Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice. Clinical Cancer Research, 11(20), 7490–7498. doi: 10.1158/1078-0432.CCR-05-1192.
Alqahtani, A., Khan, Z., Alloghbi, A., Said Ahmed, T. S., Ashraf, M., & Hammouda, D. M. (2019). Hepatocellular carcinoma: Molecular mechanisms and targeted therapies. Medicina (Kaunas), 55(9), 526. doi: 10.3390/medicina55090526.
Aune, D., Lau, R., Chan, D. S., Vieira, R., Greenwood, D. C., Kampman, E., & Norat, T. (2011). Nonlinear reduction in risk for colorectal cancer by fruit and vegetable intake based on meta-analysis of prospective studies. Gastroenterology, 141(1), 106–118. doi: 10.1053/j.gastro.2011.04.013.
Baek, S., Kang, N. J., Popowicz, G. M., Arciniega, M., Jung, S. K., Byun, S., …. Lee, K. W. (2013). Structural and functional analysis of the natural JNK1 inhibitor quercetagetin. Journal of Molecular Biology, 425(2), 411–423. doi: 10.1016/j.jmb.2012.10.019.
Baselga, J., Campone, M., Piccart, M., Burris, H. A., Rugo, H. S., Sahmoud, … Hortobagyi, G. N. (2012). Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer. The New England Journal of Medicine, 366(6), 520–529. doi: 10.1056/NEJMoa1109653.
Bhattacharya, S., Darjatmoko, S. R., & Polans, A. S. (2011). Resveratrol modulates the malignant properties of cutaneous melanoma through changes in the activation and attenuation of the antiapoptotic protooncogenic protein Akt/PKB. Melanoma Research, 21(3), 180–187. doi: 10.1097/CMR.0b013e3283456dfc.
Bian, Y., Wei, J., Zhao, C., & Li, G. (2020). Natural polyphenols targeting senescence: A novel prevention and therapy strategy for cancer. International Journal of Molecular Sciences, 21(2), 684. doi: 10.3390/ijms21020684.
Block, K. I., Koch, A. C., Mead, M. N., Tothy, P. K., Newman, R. A., & Gyllenhaal, C. (2008). Impact of antioxidant supplementation on chemotherapeutic toxicity: a systematic review of the evidence from randomized controlled trials. International Journal of Cancer, 123(6), 1227–1239. doi: 10.1002/ijc.23754.
Bode, A. M., & Dong, Z. (2013). Signal transduction and molecular targets of selected flavonoids. Antioxidants & Redox Signaling, 19(2), 163–180. doi: 10.1089/ars.2013.5251.
Boye, K., & Maelandsmo, G. M. (2010). S100A4 and metastasis: a small actor playing many roles. The American Journal of Pathology, 176(2), 528–535. doi: 10.2353/ajpath.2010.090526.
Casagrande, F., & Darbon, J. M. (2001). Effects of structurally related flavonoids on cell cycle progression of human melanoma cells: regulation of cyclin-dependent kinases CDK2 and CDK1. Biochemical Pharmacology, 61(10), 1205–1215. doi: 10.1016/s0006-2952(01)00583-4.
Casaletto, J. B., & McClatchey, A. I. (2012). Spatial regulation of receptor tyrosine kinases in development and cancer. Nature Reviews. Cancer, 12(6), 387–400. doi: 10.1038/nrc3277.
Chang, J. H., Lai, S. L., Chen, W. S., Hung, W. Y., Chow, J. M., Hsiao, …. Chien, M. H. (2017). Quercetin suppresses the metastatic ability of lung cancer through inhibiting Snail-dependent Akt activation and Snail-independent ADAM9 expression pathways. Biochimica et Biophysica Acta. Molecular Cell Research, 1864(10), 1746–1758. doi: 10.1016/j.bbamcr.2017.06.017.
Chen, J. K., Peng, S. F., Lai, K. C., Liu, H. C., Huang, Y. P., Lin, C. C., … Chung, J. G. (2019). Fistein suppresses human osteosarcoma U-2 OS cell migration and invasion via affecting FAK, uPA and NF-ĸB signaling pathway in vitro. In vivo (Athens), 33(3), 801–810. doi: 10.21873/invivo.11542.
Chiang, S. P., Cabrera, R. M., & Segall, J. E. (2016). Tumor cell intravasation. American Journal of Physiology. Cell Physiology, 311(1), C1–C14. doi: 10.1152/ajpcell.00238.2015.
Chien, H. W., Wang, K., Chang, Y. Y., Hsieh, Y. H., Yu, N. Y., Yang, S. F., & Lin, H. W. (2019). Kaempferol suppresses cell migration through the activation of the ERK signaling pathways in ARPE-19 cells. Environmental Toxicology, 34(3), 312–318. doi: 10.1002/tox.22686.
Ci, Y., Zhang, Y., Liu, Y., Lu, S., Cao, J., Li, H., …. Han, M. (2018). Myricetin suppresses breast cancer metastasis through down-regulating the activity of matrix metalloproteinase (MMP)-2/9. Phytotherapy Research, 32(7), 1373–1381. doi: 10.1002/ptr.6071.
De Stefanis, D., Scimè, S., Accomazzo, S., Catti, A., Occhipinti, A., Bertea, C. M., & Costelli, P. (2019). Anti-proliferative effects of an extra-virgin olive oil extract enriched in ligstroside aglycone and oleocanthal on human liver cancer cell lines. Cancers, 11(11), 1640. doi: 10.3390/cancers11111640.
Dhar, S., Kumar, A., Li, K., Tzivion, G., & Levenson, A. S. (2015b). Resveratrol regulates PTEN/Akt pathway through inhibition of MTA1/HDAC unit of the NuRD complex in prostate cancer. Biochimica et Biophysica Acta, 1853(2), 265–275. doi: 10.1016/j.bbamcr.2014.11.004.
Dhar, S., Kumar, A., Rimando, A. M., Zhang, X., & Levenson, A. S. (2015a). Resveratrol and pterostilbene epigenetically restore PTEN expression by targeting oncomiRs of the miR-17 family in prostate cancer. Oncotarget, 6(29), 27214–27226. doi: 10.18632/oncotarget.4877.
Durazzo, A., Lucarini, M., Souto, E. B., Cicala, C., Caiazzo, E., Izzo, A. A., … Santini, A. (2019). Polyphenols: A concise overview on the chemistry, occurrence, and human health. Phytotherapy Research, 33(9), 2221–2243. doi: 10.1002/ptr.6419.
Fan, J. J., Hsu, W. H., Lee, K. H., Chen, K. C., Lin, C. W., Lee, Y. A., …. Cheng, C. H. (2019). Dietary flavonoids luteolin and quercetin inhibit migration and invasion of squamous carcinoma through eeduction of Src/Stat3/S100A7 signaling. Antioxidants (Basel), 8(11), 557. doi: 10.3390/antiox8110557.
Feldman, M. E., & Shokat, K. M. (2010). New inhibitors of the PI3K-Akt-mTOR pathway: insights into mTOR signaling from a new generation of Tor Kinase Domain Inhibitors (TORKinibs). Current Topics in Microbiology and Immunology, 347, 241–262. doi: 10.1007/82_2010_64.
Feng, J., Song, D., Jiang, S., Yang, X., Ding, T., Zhang, H., …. Yin, Q. (2018). Quercetin restrains TGF-β1-induced epithelial-mesenchymal transition by inhibiting Twist1 and regulating E-cadherin expression. Biochemical and Biophysical Research Communications, 498(1), 132–138. doi: 10.1016/j.bbrc.2018.02.044.
Ferlay, J., Colombet, M., Soerjomataram, I., Mathers, C., Parkin, D. M., Piñeros, M., …. Bray, F. (2019). Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. International Journal of Cancer, 144(8), 1941–1953. doi: 10.1002/ijc.31937.
Fitzner, K., Oteng-Mensah, F., Donley, P., & Heckinger, E. (2017). Safety of cancer therapies: At what cost?. Population Health Management, 20(4), 318–328. doi: 10.1089/pop.2016.0097.
Gonzalez, H., Robles, I., & Werb, Z. (2018). Innate and acquired immune surveillance in the postdissemination phase of metastasis. The FEBS Journal, 285(4), 654–664. doi: 10.1111/febs.14325
Haibe, Y., Kreidieh, M., El Hajj, H., Khalifeh, I., Mukherji, D., Temraz, S., & Shamseddine, A. (2020). Resistance mechanisms to anti-angiogenic therapies in cancer. Frontiers in Oncology, 10, 221. doi: 10.3389/fonc.2020.00221.
Hamidi, H., & Ivaska, J. (2018). Every step of the way: integrins in cancer progression and metastasis. Nature Reviews. Cancer, 18(9), 533–548. doi: 10.1038/s41568-018-0038-z.
He, Z., Huang, J., Xu, Y., Zhang, X., Teng, Y., Huang, C., …. Sun, W. (2015). Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer. Oncotarget, 6(39), 42150–42168. doi: 10.18632/oncotarget.6243.
He, Z., Tang, F., Ermakova, S., Li, M., Zhao, Q., Cho, Y. Y., …. Dong, Z. (2008). Fyn is a novel target of (-)-epigallocatechin gallate in the inhibition of JB6 Cl41 cell transformation. Molecular Carcinogenesis, 47(3), 172–183. doi: 10.1002/mc.20299.
Hendriks, W. J., Elson, A., Harroch, S., Pulido, R., Stoker, A., & den Hertog, J. (2013). Protein tyrosine phosphatases in health and disease. The FEBS Journal, 280(2), 708–730. doi: 10.1111/febs.12000.
. Hong, M., Wang, N., Tan, H. Y., Tsao, S. W., & Feng, Y. (2015). MicroRNAs and Chinese medicinal herbs: New possibilities in cancer therapy. Cancers, 7(3), 1643–1657. doi: 10.3390/cancers7030855.
Hou, D. X., & Kumamoto, T. (2010). Flavonoids as protein kinase inhibitors for cancer chemoprevention: direct binding and molecular modeling. Antioxidants & Redox Signaling, 13(5), 691–719. doi: 10.1089/ars.2009.2816.
Hung, T. W., Chen, P. N., Wu, H. C., Wu, S. W., Tsai, P. Y., Hsieh, Y. S., & Chang, H. R. (2017). Kaempferol inhibits the invasion and migration of renal cancer cells through the downregulation of AKT and FAK pathways. International Journal of Medical Sciences, 14(10), 984–993. doi: 10.7150/ijms.20336.
Hussain, S. A., & Marouf, B. H. (2013). Silibinin improves the cytotoxicity of methotrexate in chemo resistant human rhabdomyosarcoma cell lines. Saudi Medical Journal, 34(11), 1145–1150. PMID: 24252892.
Inan, S., & Hayran, M. (2019). Cell signaling pathways related to epithelial mesenchymal transition in cancer metastasis. Critical Reviews in Oncogenesis, 24(1), 47–54. doi: 10.1615/CritRevOncog.2018029509.
Jang, M., Cai, L., Udeani, G. O., Slowing, K. V., Thomas, C. F., Beecher, C. W., …. Pezzuto, J. M. (1997). Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science (New York), 275(5297), 218–220. doi: 10.1126/science.275.5297.218.
Ji, Q., Liu, X., Fu, X., Zhang, L., Sui, H., Zhou, L., …. Li, Q. (2013). Resveratrol inhibits invasion and metastasis of colorectal cancer cells via MALAT1 mediated Wnt/β-catenin signal pathway. PloS One, 8(11), e78700. doi: 10.1371/journal.pone.0078700.
Jung, Y. D., & Ellis, L. M. (2001). Inhibition of tumour invasion and angiogenesis by epigallocatechin gallate (EGCG), a major component of green tea. International Journal of Experimental Pathology, 82(6), 309–316. doi: 10.1046/j.1365-2613.2001.00205.x.
Kang, N. J., Lee, K. W., Lee, D. E., Rogozin, E. A., Bode, A. M., Lee, H. J., & Dong, Z. (2008). Cocoa procyanidins suppress transformation by inhibiting mitogen-activated protein kinase kinase. The Journal of Biological Chemistry, 283(30), 20664–20673. doi: 10.1074/jbc.M800263200.
Khan, H., Reale, M., Ullah, H., Sureda, A., Tejada, S., Wang, Y., …. Xiao, J. (2020). Anti-cancer effects of polyphenols via targeting P53 signaling pathway: updates and future directions. Biotechnology Advances, 38, 107385. doi: 10.1016/j.biotechadv.2019.04.007.
Kim, E. K., & Choi, E. J. (2010). Pathological roles of MAPK signaling pathways in human diseases. Biochimica et Biophysica Acta, 1802(4), 396–405. doi: 10.1016/j.bbadis.2009.12.009.
Kim, J. K., & Park, S. U. (2018). Quercetin and its role in biological functions: an updated review. EXCLI Journal, 17, 856–863. doi: 10.17179/excli2018-1538.
Kim, W., Lee, W. B., Lee, J., Min, B. I., Lee, H., & Cho, S. H. (2015). Traditional herbal medicine as adjunctive therapy for nasopharyngeal cancer: a systematic review and meta-analysis. Integrative Cancer Therapies, 14(3), 212–220. doi: 10.1177/1534735415572881.
Kotecha, R., Takami, A., & Espinoza, J. L. (2016). Dietary phytochemicals and cancer chemoprevention: a review of the clinical evidence. Oncotarget, 7(32), 52517–52529. doi: 10.18632/oncotarget.9593.
Kuo, Y. T., Liao, H. H., Chiang, J. H., Wu, M. Y., Chen, B. C., Chang, C. M., …. Yen, H. R. (2018). Complementary Chinese herbal medicine therapy improves survival of patients with pancreatic cancer in Taiwan: A nationwide population-based cohort study. Integrative Cancer Therapies, 17(2), 411–422. doi: 10.1177/1534735417722224.
Lagoa, R., Marques-da-Silva, D., Diniz, M., Daglia, M., & Bishayee, A. (2020). Molecular mechanisms linking environmental toxicants to cancer development: Significance for protective interventions with polyphenols. Seminars in Cancer Biology, S1044-579X(20)30035-3. doi: 10.1016/j.semcancer.2020.02.002.
Lee, D. E., Lee, K. W., Song, N. R., Seo, S. K., Heo, Y. S., Kang, N. J., …. Dong, Z. (2010). 7,3',4'-Trihydroxyisoflavone inhibits epidermal growth factor-induced proliferation and transformation of JB6 P+ mouse epidermal cells by suppressing cyclin-dependent kinases and phosphatidylinositol 3-kinase. The Journal of Biological Chemistry, 285(28), 21458–21466. doi: 10.1074/jbc.M109.094797.
Leo, M. S., & Sivamani, R. K. (2014). Phytochemical modulation of the Akt/mTOR pathway and its potential use in cutaneous disease. Archives of Dermatological Research, 306(10), 861–871. doi: 10.1007/s00403-014-1480-8.
Li, H., & Chen, C. (2018). Quercetin has antimetastatic effects on gastric cancer cells via the interruption of uPA/uPAR function by modulating NF-κb, PKC-δ, ERK1/2, and AMPKα. Integrative Cancer Therapies, 17(2), 511–523. doi: 10.1177/1534735417696702.
Li, J., Gong, X., Jiang, R., Lin, D., Zhou, T., Zhang, A., …. Li, H. (2018). Fisetin inhibited growth and metastasis of triple-negative breast cancer by reversing epithelial-to-mesenchymal transition via PTEN/Akt/GSK3β signal pathway. Frontiers in Pharmacology, 9, 772. doi: 10.3389/fphar.2018.00772.
Li, M., Guan, X., Sun, Y., Mi, J., Shu, X., Liu, F., & Li, C. (2014). miR-92a family and their target genes in tumorigenesis and metastasis. Experimental Cell Research, 323(1), 1–6. doi: 10.1016/j.yexcr.2013.12.025.
Lin, S. R., Fu, Y. S., Tsai, M. J., Cheng, H., & Weng, C. F. (2017). Natural compounds from herbs that can potentially execute as autophagy inducers for cancer therapy. International Journal of Molecular Sciences, 18(7), 1412. doi: 10.3390/ijms18071412.
Liu, D., He, B., Lin, L., Malhotra, A., & Yuan, N. (2019). Potential of curcumin and resveratrol as biochemical and biophysical modulators during lung cancer in rats. Drug and Chemical Toxicology, 42(3), 328–334. doi: 10.1080/01480545.2018.1523921.
Liu, P., Liang, B., Liu, M., Lebbink, J., Li, S., Qian, M., …. Smits, R. (2020). Oncogenic mutations in Armadillo repeats 5 and 6 of β-catenin reduce binding to APC, increasing signaling and transcription of target genes. Gastroenterology, 158(4), 1029–1043.e10. doi: 10.1053/j.gastro.2019.11.302.
Liu, T., Chi, H., Chen, J., Chen, C., Huang, Y., Xi, H., …. Si, Y. (2017). Curcumin suppresses proliferation and in vitro invasion of human prostate cancer stem cells by ceRNA effect of miR-145 and lncRNA-ROR. Gene, 631, 29–38. doi: 10.1016/j.gene.2017.08.008.
Luo, H., Rankin, G. O., Liu, L., Daddysman, M. K., Jiang, B. H., & Chen, Y. C. (2009). Kaempferol inhibits angiogenesis and VEGF expression through both HIF dependent and independent pathways in human ovarian cancer cells. Nutrition and Cancer, 61(4), 554–563. doi: 10.1080/01635580802666281.
Mahajan, K., & Mahajan, N. P. (2015). Cross talk of tyrosine kinases with the DNA damage signaling pathways. Nucleic Acids Research, 43(22), 10588–10601. doi: 10.1093/nar/gkv1166.
Maruca, A., Catalano, R., Bagetta, D., Mesiti, F., Ambrosio, F. A., Romeo, I., …. Lupia, A. (2019). The Mediterranean diet as source of bioactive compounds with multi-targeting anti-cancer profile. European Journal of Medicinal Chemistry, 181, 111579. doi: 10.1016/j.ejmech.2019.111579.
McCubrey, J. A., Steelman, L. S., Chappell, W. H., Abrams, S. L., Wong, E. W., Chang, F., ……, Franklin, R. A. (2007). Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance. Biochimica et Biophysica Acta, 1773(8), 1263–1284. doi: 10.1016/j.bbamcr.2006.10.001.
Mileo, A. M., Di Venere, D., Mardente, S., & Miccadei, S. (2020). Artichoke polyphenols sensitize human breast cancer cells to chemotherapeutic drugs via a ROS-mediated downregulation of Flap endonuclease 1. Oxidative Medicine and Cellular Longevity, 2020, 7965435. doi: 10.1155/2020/7965435.
Mishra, S., Verma, S. S., Rai, V., Awasthee, N., Chava, S., Hui, K. M., …. Gupta, S. C. (2019). Long non-coding RNAs are emerging targets of phytochemicals for cancer and other chronic diseases. Cellular and Molecular Life Sciences, 76(10), 1947–1966. doi: 10.1007/s00018-019-03053-0.
Nikolaou, S., & Machesky, L. M. (2020). The stressful tumour environment drives plasticity of cell migration programmes, contributing to metastasis. The Journal of Pathology, 250(5), 612–623. doi: 10.1002/path.5395.
Pachmayr, E., Treese, C., & Stein, U. (2017). Underlying mechanisms for distant metastasis - Molecular biology. Visceral Medicine, 33(1), 11–20. doi: 10.1159/000454696.
Pal, H. C., Sharma, S., Strickland, L. R., Katiyar, S. K., Ballestas, M. E., Athar, M., …. Afaq, F. (2014). Fisetin inhibits human melanoma cell invasion through promotion of mesenchymal to epithelial transition and by targeting MAPK and NFκB signaling pathways. PloS One, 9(1), e86338. doi: 10.1371/journal.pone.0086338.
Park, J. W., & Han, J. W. (2019). Targeting epigenetics for cancer therapy. Archives of Pharmacal Research, 42(2), 159–170. doi: 10.1007/s12272-019-01126-z.
Pathak, A. K., Bhutani, M., Guleria, R., Bal, S., Mohan, A., Mohanti, B. K., …. Kochupillai, V. (2005). Chemotherapy alone vs. chemotherapy plus high dose multiple antioxidants in patients with advanced non small cell lung cancer. Journal of the American College of Nutrition, 24(1), 16–21. doi: 10.1080/07315724.2005.10719438.
Psaila, B., & Lyden, D. (2009). The metastatic niche: adapting the foreign soil. Nature Reviews. Cancer, 9(4), 285–293. doi: 10.1038/nrc2621.
Qamar, H., Rehman, S., & Chauhan, D. K. (2019). Current status and future perspective for research on medicinal plants with anticancerous activity and minimum cytotoxic value. Current Drug Targets, 20(12), 1227–1243. doi: 10.2174/1389450120666190429120314.
Reddivari, L., Charepalli, V., Radhakrishnan, S., Vadde, R., Elias, R. J., Lambert, J. D., & Vanamala, J. K. (2016). Grape compounds suppress colon cancer stem cells in vitro and in a rodent model of colon carcinogenesis. BMC Complementary and Alternative Medicine, 16, 278. doi: 10.1186/s12906-016-1254-2.
Riboli, E., & Norat, T. (2003). Epidemiologic evidence of the protective effect of fruit and vegetables on cancer risk. The American Journal of Clinical Nutrition, 78(3 Suppl), 559S–569S. doi: 10.1093/ajcn/78.3.559S.
Russo, G. L., Russo, M., Spagnuolo, C., Tedesco, I., Bilotto, S., Iannitti, R., & Palumbo, R. (2014). Quercetin: a pleiotropic kinase inhibitor against cancer. Cancer Treatment and Research, 159, 185–205. doi: 10.1007/978-3-642-38007-5_11.
Sakle, N. S., More, S. A., Dhawale, S. A., & Mokale, S. N. (2020). Targeting small molecule tyrosine kinases by polyphenols: New move towards anti-tumor drug discovery. Current Drug Discovery Technologies, 17(5), 585–615. doi: 10.2174/1570163816666190808120843.
Sarkar, F. H., & Li, Y. (2006). Using chemopreventive agents to enhance the efficacy of cancer therapy. Cancer Research, 66(7), 3347–3350. doi: 10.1158/0008-5472.CAN-05-4526.
Starok, M., Preira, P., Vayssade, M., Haupt, K., Salomé, L., & Rossi, C. (2015). EGFR inhibition by curcumin in cancer cells: A dual mode of action. Biomacromolecules, 16(5), 1634–1642. doi: 10.1021/acs.biomac.5b00229.
Suganuma, M., Saha, A., & Fujiki, H. (2011). New cancer treatment strategy using combination of green tea catechins and anticancer drugs. Cancer Science, 102(2), 317–323. doi: 10.1111/j.1349-7006.2010.01805.x.
Summers, M. A., McDonald, M. M., & Croucher, P. I. (2020). Cancer cell dormancy in metastasis. Cold Spring Harbor Perspectives in Medicine, 10(4), a037556. doi: 10.1101/cshperspect.a037556.
Sun, X. D., Liu, X. E., & Huang, D. S. (2012). Curcumin induces apoptosis of triple-negative breast cancer cells by inhibition of EGFR expression. Molecular Medicine Reports, 6(6), 1267–1270. doi: 10.3892/mmr.2012.1103.
Tabasum, S., & Singh, R. P. (2019). Fisetin suppresses migration, invasion and stem-cell-like phenotype of human non-small cell lung carcinoma cells via attenuation of epithelial to mesenchymal transition. Chemico-Biological Interactions, 303, 14–21. doi: 10.1016/j.cbi.2019.02.020.
Tabrez, S., Jabir, N. R., Adhami, V. M., Khan, M. I., Moulay, M., Kamal, M. A., & Mukhtar, H. (2020). Nanoencapsulated dietary polyphenols for cancer prevention and treatment: successes and challenges. Nanomedicine (London), 15(11), 1147–1162. doi: 10.2217/nnm-2019-0398.
Tadesse, S., Yu, M., Kumarasiri, M., Le, B. T., & Wang, S. (2015). Targeting CDK6 in cancer: State of the art and new insights. Cell Cycle (Georgetown), 14(20), 3220–3230. doi: 10.1080/15384101.2015.1084445.
Temviriyanukul, P., Kittibunchakul, S., Trisonthi, P., Inthachat, W., Siriwan, D., & Suttisansanee, U. (2021). Analysis of phytonutrients, anti-mutagenic and chemopreventive effects of tropical fruit extracts. Foods (Basel), 10(11), 2600. doi: 10.3390/foods10112600.
Tsao R. (2010). Chemistry and biochemistry of dietary polyphenols. Nutrients, 2(12), 1231–1246. doi: 10.3390/nu2121231.
Tsimberidou, A. M., Fountzilas, E., Nikanjam, M., & Kurzrock, R. (2020). Review of precision cancer medicine: Evolution of the treatment paradigm. Cancer Treatment Reviews, 86, 102019. doi: 10.1016/j.ctrv.2020.102019.
Wang, H., Zhang, H., Tang, L., Chen, H., Wu, C., Zhao, M., …. Liu, G. (2013). Resveratrol inhibits TGF-β1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis. Toxicology, 303, 139–146. doi: 10.1016/j.tox.2012.09.017.
Wang, M., Yu, T., Zhu, C., Sun, H., Qiu, Y., Zhu, X., & Li, J. (2014). Resveratrol triggers protective autophagy through the ceramide/Akt/mTOR pathway in melanoma B16 cells. Nutrition and Cancer, 66(3), 435–440. doi: 10.1080/01635581.2013.878738.
Wang, Z. Y., Huang, M. T., Lou, Y. R., Xie, J. G., Reuhl, K. R., Newmark, H. L., …. Conney, A. H. (1994). Inhibitory effects of black tea, green tea, decaffeinated black tea, and decaffeinated green tea on ultraviolet B light-induced skin carcinogenesis in 7,12-dimethylbenz[a]anthracene-initiated SKH-1 mice. Cancer Research, 54(13), 3428–3435. PMID: 8012962
Weng, C. J., & Yen, G. C. (2012). Chemopreventive effects of dietary phytochemicals against cancer invasion and metastasis: phenolic acids, monophenol, polyphenol, and their derivatives. Cancer Treatment Reviews, 38(1), 76–87. doi: 10.1016/j.ctrv.2011.03.001.
Wessner, B., Strasser, E. M., Koitz, N., Schmuckenschlager, C., Unger-Manhart, N., & Roth, E. (2007). Green tea polyphenol administration partly ameliorates chemotherapy-induced side effects in the small intestine of mice. The Journal of Nutrition, 137(3), 634–640. doi: 10.1093/jn/137.3.634.
Wilmes, S., Hafer, M., Vuorio, J., Tucker, J. A., Winkelmann, H., Löchte, S., …. Piehler, J. (2020). Mechanism of homodimeric cytokine receptor activation and dysregulation by oncogenic mutations. Science (New York), 367(6478), 643–652. doi: 10.1126/science.aaw3242.
Yao, X., Jiang, W., Yu, D., & Yan, Z. (2019). Luteolin inhibits proliferation and induces apoptosis of human melanoma cells in vivo and in vitro by suppressing MMP-2 and MMP-9 through the PI3K/AKT pathway. Food & Function, 10(2), 703–712. doi: 10.1039/c8fo02013b.
Ye, C., Zhang, C., Huang, H., Yang, B., Xiao, G., Kong, D., …. Sun, Y. (2018). The natural compound myricetin effectively represses the malignant progression of prostate cancer by inhibiting PIM1 and disrupting the PIM1/CXCR4 interaction. International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology, 48(3), 1230–1244. doi: 10.1159/000492009.
Zhang, Q., Cui, Y., Zhang, J., Kenjiabieke, J., & Aerxiding, P. (2020). Comparison of the characteristics of uncommon epidermal growth factor receptor (EGFR) mutations and EGFR-tyrosine kinase inhibitor treatment in patients with non-small cell lung cancer from different ethnic groups. Experimental and Therapeutic Medicine, 19(6), 3513–3520. doi: 10.3892/etm.2020.8612.
Zhang, Y., Du, Z., & Zhang, M. (2016). Biomarker development in MET-targeted therapy. Oncotarget, 7(24), 37370–37389. doi: 10.18632/oncotarget.8276.
Zhou, H., & Huang, S. (2011). Role of mTOR signaling in tumor cell motility, invasion and metastasis. Current Protein & Peptide Science, 12(1), 30–42. doi: 10.2174/138920311795659407.
Zugazagoitia, J., Guedes, C., Ponce, S., Ferrer, I., Molina-Pinelo, S., & Paz-Ares, L. (2016). Current challenges in cancer treatment. Clinical Therapeutics, 38(7), 1551–1566. doi: 10.1016/j.clinthera.2016.03.026.
How to Cite
Hussain, S., & Alhadidi, Q. M. (2022). Polyphenols as Tyrosine Kinase Inhibitors for the Treatment of Metastatic Cancers: Current and Future Perspective . Indonesian Journal of Pharmacy, 33(3), 366-380. https://doi.org/10.22146/ijp.3844
Review Article